Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

ClinicalTrials.gov ID: NCT00078312

Public ClinicalTrials.gov record NCT00078312. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and tolerability of Armodafinil (CEP-10953) administered on a flexible-dosage regimen of 100 to 250 mg/day for up to 12 months to patients with excessive sleepiness associated with a current diagnosis of narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS)(regular users of nasal continuous positive airway pressure \[nCPAP\] therapy), or chronic shift work sleep disorder (SWSD).

Study identification

NCT ID
NCT00078312
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
328 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2004 (Type not available)
Primary completion
Jul 2006 (Actual)
Completion
Jul 2006 (Actual)
Last update posted
Jul 19, 2013

2004 – 2006

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
38
Facility City State ZIP Site status
Pivotal Research Centers Peoria Arizona 85381 —
Central Phoenix Medical Clinic, LLC Phoenix Arizona 85014 —
Radiant Research - Tucson Tucson Arizona 85710 —
Central Arkansas Research Hot Springs Arkansas 71913 —
Arkansas Center for Sleep Medicine Little Rock Arkansas 72205 —
Bay Area Research Institute Lafayette California 94549 —
Pharmacology Research Institute Los Alamitos California 90720 —
Neuro-Therapeutics Inc. Pasadena California 91105 —
Anderson Clinical Research Redlands California 92374 —
Synergy Clinical Research Center San Diego California 92105 —
BMR HealthQuest Clinical Trials San Diego California 92123 —
Rocky Mountain Center for Clinical Research Wheat Ridge Colorado 80033 —
Therafirst Medical Centers Fort Lauderdale Florida 33308 —
Precision Research Hallandale Florida 33009 —
Renstar Medical Research Ocala Florida 34471 —
Clinical Research Group of St. Petersburg St. Petersburg Florida 33707 —
Radiant Research, Boise Boise Idaho 83704 —
Herron Medical Center, Ltd. Chicago Illinois 60610 —
Radiant Research, Chicago Chicago Illinois 60610 —
Radiant Research Alexian Brothers Elk Grove Village Illinois 60007 —
Henry W. Lahmeyer, MD and Associates Northfield Illinois 60093 —
Vince and Associates Clinical Research Overland Park Kansas 66211 —
NeuroTrials Research of New Orleans, LLC Metairie Louisiana 70001 —
Marc Raphaelson, MD, PA Frederick Maryland 21702 —
Michigan Head-Pain Neurological Institute Ann Arbor Michigan 48104 —
Somnos Laboratories, Inc Lincoln Nebraska 68510 —
Clinical Research Center of Nevada Las Vegas Nevada 89104 —
CNS Research Institute, PC Clementon New Jersey 08021 —
Long Island Clinical Research Associates, LLP Great Neck New York 11021 —
North Shore University Hospital Manhasset New York 11030 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
North Coast Clinical Trials, Inc Beachwood Ohio 44122 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Clinical Research Studies Oklahoma City Oklahoma 73109 —
Oregon Health and Science University Portland Oregon 97239 —
Lehigh Valley Hospital Hospital Allentown Pennsylvania 18105 —
Center for Sleep Disorders, Inc. Pottstown Pennsylvania 19464 —
SleepMed of South Carolina Columbia South Carolina 29201 —
Radiant Research, San Antonio San Antonio Texas 78229 —
Radiant Research Salt Lake City Utah 84107 —
Northwest Clinical Research Center Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00078312, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00078312 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →